Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.988365
Abstract: Introduction Immune checkpoint inhibitors are used in the treatment of various cancers and have been extensively researched with regard to inflammatory and autoimmune diseases. However, this revolutionary therapeutic strategy often provokes critical auto-inflammatory adverse events,… read more here.
Keywords: checkpoint inhibitors; immune checkpoint; antagonistic targeting; osteoclastogenesis ... See more keywords